Suzhou Novoprotein Scientific Co (SHSE:688137) Interest Coverage: 0 (At Loss) (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688137 Suzhou Novoprotein Scientific Co Ltd SHSE:688137
62 GF Score
Price ¥34.30
GF Value ¥37.73
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Suzhou Novoprotein Scientific Co Interest Coverage?

Suzhou Novoprotein Scientific Co SHSE:688137 -1.32% 62 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates SHSE:688137 with a GF Score™ of 62/100 and a GF Value™ of ¥37.73 (Fairly Valued). The stock has 2 warning signs investors should review. Among 376 Biotechnology companies, Suzhou Novoprotein Scientific Co ranks worse than 265957.18% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Suzhou Novoprotein Scientific Co's Operating Income for the three months ended in Mar. 2026 was ¥-11.5 Mil. Suzhou Novoprotein Scientific Co's Interest Expense for the three months ended in Mar. 2026 was ¥-0.6 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Suzhou Novoprotein Scientific Co's Interest Coverage or its related term are showing as below:


SHSE:688137's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.135
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Suzhou Novoprotein Scientific Co  (SHSE:688137) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Suzhou Novoprotein Scientific Co Interest Coverage Related Terms


Suzhou Novoprotein Scientific Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Suzhou Novoprotein Scientific Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Suzhou Novoprotein Scientific Co Interest Coverage Chart

Suzhou Novoprotein Scientific Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial 107.76 27.90 0.00 0.00 0.00

Suzhou Novoprotein Scientific Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SHSE:688137 vs VRTX, REGN, RVMD: Interest Coverage Comparison

For the Biotechnology subindustry, Suzhou Novoprotein Scientific Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Novoprotein Scientific Co Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Novoprotein Scientific Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Suzhou Novoprotein Scientific Co's Interest Coverage falls into.


SHSE:688137
62GF Score
Suzhou Novoprotein Scientific Co Ltd SHSE:688137
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Novoprotein Scientific Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Suzhou Novoprotein Scientific Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Suzhou Novoprotein Scientific Co's Interest Expense was ¥-2.5 Mil. Its Operating Income was ¥-66.7 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥45.6 Mil.

Suzhou Novoprotein Scientific Co did not have earnings to cover the interest expense.

Suzhou Novoprotein Scientific Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Suzhou Novoprotein Scientific Co's Interest Expense was ¥-0.6 Mil. Its Operating Income was ¥-11.5 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥43.4 Mil.

Suzhou Novoprotein Scientific Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Suzhou Novoprotein Scientific Co (SHSE:688137) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Suzhou Novoprotein Scientific Co and its competitors. According to the industry distribution chart, Suzhou Novoprotein Scientific Co ranks #999999 out of 376 companies in the Biotechnology industry.
Is Suzhou Novoprotein Scientific Co's Interest Coverage too high?
Suzhou Novoprotein Scientific Co's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Suzhou Novoprotein Scientific Co ranks #999999 out of 376 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Suzhou Novoprotein Scientific Co ranks #999999 out of 376 companies for Interest Coverage. This places Suzhou Novoprotein Scientific Co in the lower half of its industry. The industry median Interest Coverage is 106.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.14, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Suzhou Novoprotein Scientific Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Novoprotein Scientific Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.73, compared to a current price of ¥34.30 — trading 9.1% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Suzhou Novoprotein Scientific Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be undervalued. The current stock price of ¥34.30 is trading 9.1% below its estimated GF Value™ of ¥37.73. GuruFocus considers Suzhou Novoprotein Scientific Co to be Fairly Valued.

Key valuation signals for SHSE:688137:

  • Interest Coverage: 0 (At Loss)
  • GF Value™: ¥37.73 vs. price of ¥34.30 (9.1% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suzhou Novoprotein Scientific Co Business Description

Address No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
62GF Score

Get the complete analysis for SHSE:688137

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥34.30
Price
¥37.73
GF Value